EPCAM and neoplasm: To accomplish this, the EpCAM-specific DARPins Ec4.1 and Ac2 were conjugated to NIRF dye IRDye 800CW, after which their binding and NIRF imaging potential were evaluated using in vitro and in vivo tumor models [28].